Results from our survey assessing adverse reactions in healthcare staff working in Level 3 barrier protection personal protective equipment to treat COVID-19.
| Survey assessing adverse reactions in healthcare staff working in L3PPE to treat COVID-19 | |||||
|---|---|---|---|---|---|
| Doctors (n=21) | Nurses (n=108) | Juniors (n=50) | Seniors (n=79) | ||
| Facial skin indentation | 13 (61.9%) | 80 (74.1%) | 37 (74.0%) | 56 (70.9%) | |
| Rash | 1 (4.8%) | 28 (25.9%) | 12 (24.0%) | 17 (21.5%) | |
| Dermatitis | 3 (14.3%) | 27 (25.0%) | 14 (46.7%) | 16 (20.3%) | |
| Respiratory difficulties | 8 (38.1%) | 64 (59.3%) | 31 (62.0%) | 41 (51.9%) | |
| Heat stress | 12 (57.1%) | 76 (70.4%) | 40 (80.0%) | 48 (60.8%) | |
| Dizziness | 6 (28.6%) | 57 (52.8%) | 22 (44.0%) | 41 (51.9%) | |
| Nausea | 3 (14.3%) | 28 (25.9%) | 12 (24.0%) | 19 (24.1%) | |